Skip to content

Washington, D.C. · Nonprofit

NATIONAL BREAST CANCER COALITION FUND

NATIONAL BREAST CANCER COALITION FUND (Washington, D.C.) receives grants from 76 organizations whose IRS filings report $11,483,637 to it, the largest being VANCE WALL FOUNDATION INC ($4,190,000). 41 of them have funded it in more than one year.

Revenue FY2024
$4.5M
Funders on record
76
Grants received
$11M
Net assets
$6.6M
41/76 repeat funderspeak grant-dependency 58%
01What it does

What National Breast Cancer Coalition Fund does

Mission

Nbcc's mission is "to end breast cancer through the power of action and advocacy." nbcc is made up of activists who set a programmatic and research agenda to end breast cancer and use the power of action and advocacy to fight the breast cancer status quo, overcome barriers to true progress in saving lives, and empower and train survivors and advocates to be leaders for this cause.

As stated on its FY2024 Form 990.

Programs

  1. Education and training - the center for nbcc advocacy training supplies the education, tools, training, and action that enable breast cancer survivors and other advocates to understand complex medical and scientific information and to take leadership roles in clinical, scientific, funding, and policy decision-making that affect breast cancer.the advocate leadership summit is a three-day educational and strategy-building session to train and empower breast cancer survivors and other advocates by providing information and background about breast cancer as well as the tools and tactics necessary to take a leadership role in breast cancer advocacy.project lead, nbcc's innovative science training course, is designed to help breast cancer activists influence research and public policy. An intensive two-to-six-day program, project lead prepares advocates for participation in the wide range of forums where breast cancer research decisions are made. Project lead includes:- project lead institute: annual intensive six-day course in core science training for advocate leaders to learn the language and concepts of science with a focus on the biology of breast cancer, genetics, epidemiology,…

    $1,464,701 spentof which $12,821 as grants$84,879 earned by the program
    42% of program spending
  2. Catalytic research projects and collaborations - nbcc's artemis project is centered around strategic summits, catalytic workshops, and collaborative efforts with a multi- disciplinary and diverse group of stakeholders. This advocate-led, innovative approach allows scientists, industry representatives, and regulators to work collaboratively with advocates to develop and implement strategic research plans that could have a significant impact on primary prevention and saving lives. Projects include:- artemis project for a preventive breast cancer vaccine: a strategic plan for the development of a preventive in breast cancer.- artemis project on the preventive of metastasis: determining the process by which breast cancer spreads and becomes lethal, and how to intervene to stop it. - seed grants for research: nbcc has awarded seed grants to allow scientists to begin the research required in key areas identified in the collaborative research plans.clinical trials initiative - nbcc works with industry and the research community on clinical trials that meet the criteria of nbcc's clinical trial project. We involve breast cancer activists in all aspects of clinical trial design,…

    $859,106 spent
    25% of program spending
  3. Public policy - public policy plays a significant role in all aspects of breast cancer. Nbcc focuses its public policy advocacy on priorities that will have a major impact on ending breast cancer, including those that will increase funding for meaningful breast cancer research, provide access to high-quality health care and clinical trials, and expand the influence of breast cancer advocates everywhere breast cancer decisions are made.nbcc provides members of congress and their staff up-to-date information about breast cancer and reports on research discoveries that affect policy and appropriations. Nbcc leadership often testifies before congressional committees on substantive breast cancer issues.

    $489,194 spentof which $311,000 as grants
    14% of program spending
  4. Public information, communications, and outreach - nbcc has undertaken an expansive effort to change the conversation around breast cancer to a dialogue about knowing how to end the disease.- breast cancer information campaigns: the nbcc website and print and electronic communications help educate the public with facts about breast cancer. Nbcc's expert staff analyze research studies and media coverage and present the truth behind the news.- global influence: the nbcc executive team, board of directors, and advocate leadership represent the breast cancer community, advocating on its behalf and serving on scientific, medical, and research bodies at the national and international levels.through all of these programs, nbcc supports and facilitates the research needed to end breast cancer, global access to the necessary information and lifesaving interventions, and the influence of leaders everywhere in the strategies to end breast cancer.

    $314,519 spent
    9% of program spending
  5. Grassroots advocacy field network development and support - nbcc provides resources and support to member organizations nationwide and enhances education and training among diverse populations of breast cancer activists.all organization and individual members of nbcc's national action network receive email alerts throughout the year, usually twice each month, with important information and timely actions for their advocacy. Nbcc also convenes regular conference calls and webinars for the grassroots field network to provide individualized guidance, informational materials, and peer-to-peer support.

    $297,929 spent
    9% of program spending
  6. Other programs - through the clinical trials initiative, nbcc works with the research community to involve breast cancer activists in all aspects of clinical trial design, implementation and oversight and increase the number of high quality trials conducted.

    $25,978 spent$27,800 earned by the program
    1% of program spending

The 6 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $3,451,427.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($2.5M) Expenses 100 ($3.2M) Net assets 100 ($2.0M)2018 Revenue 115 ($2.9M) Expenses 101 ($3.2M) Net assets 83 ($1.6M)2019 Revenue 138 ($3.5M) Expenses 99 ($3.2M) Net assets 97 ($1.9M)2020 Revenue 161 ($4.1M) Expenses 87 ($2.8M) Net assets 161 ($3.2M)2021 Revenue 169 ($4.3M) Expenses 85 ($2.7M) Net assets 239 ($4.7M)2022 Revenue 179 ($4.5M) Expenses 107 ($3.5M) Net assets 293 ($5.8M)2023 Revenue 174 ($4.4M) Expenses 125 ($4.1M) Net assets 310 ($6.1M)2024 Revenue 178 ($4.5M) Expenses 124 ($4.0M) Net assets 336 ($6.6M)
'17'18'19'20'21'22'23'24
Revenue (178)Expenses (124)Net assets (336)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $3.4M to $4.8M (+44%).

$2.5M
$2.1M
$2.2M
$3.4M
$4.8M
$6.0M
$6.7M
$7.1M
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2020 5% · 2021 6% · 2022 1%. Grants only. Government contracts and fees sit inside program revenue.

105% of NATIONAL BREAST CANCER COALITION FUND’s revenue is contributions — more reliant on donations than three-quarters of its peers (39% for the typical peer).

This organization
Typical peer · 4,214 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 8 reported years ran a deficit.

−$702k
’17
−$341k
’18
$284k
’19
$1.3M
’20
$1.5M
’21
$1.1M
’22
$336k
’23
$507k
’24
2.2
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Alec Call

Chair

As listed on its FY2024 Form 990.

'17'18'19'20'21'22'23'24
Listed1715171718202120
Joined·+2+2+3+2+4+7+1
No longer listed·4031262
03Who funds it

Who funds it, year by year

2017 → 2023: the base broadened from 12 funders to 32 funders, grant income rose $266k → $2.2M.

21 of 76 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 26% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

Left out of every figure on this page: $134k from one payer (the payer shares this organization's board, largest National Breast Cancer Coalition). These are real filings, and they are not money NATIONAL BREAST CANCER COALITION FUND raised.

From the IRS filings of NATIONAL BREAST CANCER COALITION FUND’s funders (the co-funder graph). Top 30 of 76 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

NATIONAL BREAST CANCER COALITION FUND leans on a few funders — its largest provides 36% of grant income and the top three 66%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

31% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund NATIONAL BREAST CANCER COALITION FUND.

36%
largest funder
66%
top three
~5
effective funders

Largest funder’s share by year: 2017 48% · 2018 23% · 2019 37% · 2020 50% · 2021 44% · 2022 60% · 2023 34% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

40% of NATIONAL BREAST CANCER COALITION FUND's funders are still giving 3 years after their first grant; 54% give in more than one year at all.

first grant+1y+2y+3y+4y+5y+6y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

NATIONAL BREAST CANCER COALITION FUND draws 99% of its grant income from funders outside Washington, D.C., across 17 states in all.

ID
MN
IL
NY
MA
OR
NJ
CT
CA
VA
DE
NC
DC
OK
GA
TX
FL

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
Washington, D.C. out of state home

Funder states come from each funder’s own filing. $2.9M arriving through sponsors registered in 11 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

NATIONAL BREAST CANCER COALITION FUND runs a healthier operating margin than half of the 3,973 housing & shelter nonprofits its size.

Operating margin11% · above the median
Months of reserve2.2mo · below the median
Revenue growth (annualized)9% · above the median

this organization peer median middle 50% of peers· 3,973 housing & shelter nonprofits $1M–$10M, FY2024

Organizations like NATIONAL BREAST CANCER COALITION FUND

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Washington, D.C.

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

86% of spending goes to programs.

Program 86%Management 6%Fundraising 8%

Governance

14
board members
93%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

57%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 29 states

NH
ND
MN
IL
WI
MI
NY
MA
OR
PA
NJ
RI
CA
KY
WV
VA
MD
NM
KS
AR
TN
NC
SC
HI
OK
MS
AL
GA
FL

Part of a family of 1 related entity

  • National Breast Cancer Coalition · exempt

Screen this organization

A dated, signed PDF of the compliance screen for NATIONAL BREAST CANCER COALITION FUND: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds NATIONAL BREAST CANCER COALITION FUND?
NATIONAL BREAST CANCER COALITION FUND (Washington, D.C.) receives grants from 76 organizations whose IRS filings report $11,483,637 to it, the largest being VANCE WALL FOUNDATION INC ($4,190,000). 41 of them have funded it in more than one year.
How many funders does NATIONAL BREAST CANCER COALITION FUND have?
IRS filings report 76 organizations giving $11,483,637 in grants to NATIONAL BREAST CANCER COALITION FUND, 41 of which have funded it in more than one year.
Who is the largest funder of NATIONAL BREAST CANCER COALITION FUND?
VANCE WALL FOUNDATION INC is the largest funder on record, with $4,190,000 in grants. The full list of funders is on this page.
How can an organization like NATIONAL BREAST CANCER COALITION FUND find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Washington, D.C.. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 76 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing